Metracor Technologies

Metracor Technologies was a medical technology company that specialized in the development of advanced hemodynamic monitoring solutions. The company's core innovation was a proprietary algorithm designed to calculate cardiac output and other critical cardiovascular parameters from a peripheral arterial pressure waveform. This technology became the foundation for the FloTrac sensor and Vigileo monitor, which allowed clinicians to monitor a patient's heart function and fluid status with significantly less invasiveness than traditional pulmonary artery catheters. By providing real-time, continuous data, Metracor's solutions improved the management of critically ill and surgical patients. In 2006, the company was acquired by Edwards Lifesciences, which integrated Metracor's technology into its market-leading critical care portfolio.